MetLife Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $191K | Buy |
92,426
+37,738
| +69% | +$78.1K | ﹤0.01% | 2222 |
|
2025
Q1 | $120K | Sell |
54,688
-18,002
| -25% | -$39.6K | ﹤0.01% | 2443 |
|
2024
Q4 | $111K | Buy |
72,690
+635
| +0.9% | +$972 | ﹤0.01% | 2570 |
|
2024
Q3 | $143K | Hold |
72,055
| – | – | ﹤0.01% | 2459 |
|
2024
Q2 | $252K | Buy |
72,055
+31,944
| +80% | +$112K | ﹤0.01% | 2104 |
|
2024
Q1 | $111K | Sell |
40,111
-13,453
| -25% | -$37.3K | ﹤0.01% | 2483 |
|
2023
Q4 | $91.1K | Hold |
53,564
| – | – | ﹤0.01% | 2645 |
|
2023
Q3 | $55.2K | Hold |
53,564
| – | – | ﹤0.01% | 2816 |
|
2023
Q2 | $62.1K | Hold |
53,564
| – | – | ﹤0.01% | 2878 |
|
2023
Q1 | $80.9K | Hold |
53,564
| – | – | ﹤0.01% | 2634 |
|
2022
Q4 | $134K | Hold |
53,564
| – | – | ﹤0.01% | 2470 |
|
2022
Q3 | $226K | Hold |
53,564
| – | – | ﹤0.01% | 2217 |
|
2022
Q2 | $149K | Hold |
53,564
| – | – | ﹤0.01% | 2498 |
|
2022
Q1 | $306K | Buy |
53,564
+20,791
| +63% | +$119K | ﹤0.01% | 2079 |
|
2021
Q4 | $299K | Hold |
32,773
| – | – | ﹤0.01% | 1818 |
|
2021
Q3 | $350K | Hold |
32,773
| – | – | ﹤0.01% | 1737 |
|
2021
Q2 | $509K | Hold |
32,773
| – | – | ﹤0.01% | 1557 |
|
2021
Q1 | $531K | Sell |
32,773
-6,301
| -16% | -$102K | ﹤0.01% | 1492 |
|
2020
Q4 | $827K | Hold |
39,074
| – | – | 0.01% | 1218 |
|
2020
Q3 | $579K | Hold |
39,074
| – | – | 0.01% | 1297 |
|
2020
Q2 | $575K | Buy |
39,074
+2,530
| +7% | +$37.2K | 0.01% | 1303 |
|
2020
Q1 | $429K | Hold |
36,544
| – | – | 0.01% | 1294 |
|
2019
Q4 | $859K | Buy |
36,544
+2,703
| +8% | +$63.5K | 0.01% | 1167 |
|
2019
Q3 | $626K | Hold |
33,841
| – | – | 0.01% | 1300 |
|
2019
Q2 | $629K | Buy |
33,841
+4,475
| +15% | +$83.2K | 0.01% | 1347 |
|
2019
Q1 | $718K | Hold |
29,366
| – | – | 0.01% | 1234 |
|
2018
Q4 | $762K | Hold |
29,366
| – | – | 0.01% | 1133 |
|
2018
Q3 | $929K | Hold |
29,366
| – | – | 0.01% | 1166 |
|
2018
Q2 | $1.14M | Buy |
29,366
+4,394
| +18% | +$171K | 0.01% | 969 |
|
2018
Q1 | $689K | Buy |
24,972
+2,926
| +13% | +$80.7K | 0.01% | 1177 |
|
2017
Q4 | $399K | Buy |
+22,046
| New | +$399K | ﹤0.01% | 1531 |
|